Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Dirix

Showing results (121-130 of 195) with videos related to

Pageof 20
Sort By:
Angiogenesis|October 28, 2019
Pathological features of vessel co-option versus sprouting angiogenesisEmily Latacz, Elisabetta Caspani, Raymond Barnhill, et al.
British Journal of Cancer|February 21, 2013
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancerD W Miles, S L de Haas, L Y Dirix, et al.
Plos One|March 4, 2014
A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samplesMelike Marsan, Gert Van den Eynden, Ridha Limame, et al.
Journal of Cutaneous Pathology|August 13, 2015
Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanomaIevgenia Pastushenko, Peter B Vermeulen, Sandra Vicente-Arregui, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group StudyC N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric studyIlse Van der Auwera, Gert G Van den Eynden, Cecile G Colpaert, et al.
Cancer Biology & Therapy|October 16, 2009
Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypesIlse Van der Auwera, Catherine Bovie, Cecilia Svensson, et al.
British Journal of Cancer|May 4, 2006
Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical studyG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies GroupL Y Dirix, F Tonnesen, J Cassidy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel nodeGert G Van den Eynden, Melanie K Vandenberghe, Pieter-Jan H van Dam, et al.
Pageof 20

Showing results (121-130 of 195) with videos related to

Sort By:
Pageof 20
Angiogenesis|October 28, 2019
Pathological features of vessel co-option versus sprouting angiogenesisEmily Latacz, Elisabetta Caspani, Raymond Barnhill, et al.
British Journal of Cancer|February 21, 2013
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancerD W Miles, S L de Haas, L Y Dirix, et al.
Plos One|March 4, 2014
A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samplesMelike Marsan, Gert Van den Eynden, Ridha Limame, et al.
Journal of Cutaneous Pathology|August 13, 2015
Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanomaIevgenia Pastushenko, Peter B Vermeulen, Sandra Vicente-Arregui, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group StudyC N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric studyIlse Van der Auwera, Gert G Van den Eynden, Cecile G Colpaert, et al.
Cancer Biology & Therapy|October 16, 2009
Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypesIlse Van der Auwera, Catherine Bovie, Cecilia Svensson, et al.
British Journal of Cancer|May 4, 2006
Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical studyG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies GroupL Y Dirix, F Tonnesen, J Cassidy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel nodeGert G Van den Eynden, Melanie K Vandenberghe, Pieter-Jan H van Dam, et al.
Pageof 20